 |
Auron Therapeutics
Last updated: October 31, 2025
CEO Kate Yen
USA | Funding: $88.4M (+)
Website: https://aurontx.com/
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. Using its proprietary machine learning models, Auron builds atlases that define the normal differentiation states of cancer cells and the pathways that drive terminal differentiation.
Website: https://aurontx.com/
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. Using its proprietary machine learning models, Auron builds atlases that define the normal differentiation states of cancer cells and the pathways that drive terminal differentiation.
